JonathanZRosenbluthMD
Oncology • Bridgewater, NJPhysician - Regional Cancer Care Associates, Central Jersey Division
Dr. Rosenbluth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 US Highway 22
Ste 3
Bridgewater, NJ 08807Phone+1 732-390-7750Fax+1 908-530-2929
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 2002 - 2005
Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1999 - 2002
Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
NJ State Medical License 2007 - 2025
GA State Medical License 2005 - 2009
PA State Medical License 2002 - 2005- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Publications & Presentations
PubMed
- 7 citationsCombination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.Dmitry Zak, Michael Styler, Jonathan Z Rosenbluth, Isadore Brodsky
Clinical Advances in Hematology & Oncology. 2005-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
